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Simian and human immunodeficiency virus type 1 (SIV and HIV-1) Nef proteins are thought to use different molecular
surfaces to mediate the protein–protein interactions required for their otherwise similar functions. This genetically separable
function suggests convergent evolution of primate lentiviruses and/or structural differences between human and nonhuman
primate cellular target proteins. However, such comparative molecular analyses have not been undertaken so far using theINTRODUCTION
The Nef protein is uniquely encoded by primate lenti-
viruses, namely, human immunodeficiency virus types 1
and 2 (HIV-1 and -2) and simian immunodeficiency virus
(SIV). Nef is critical for optimal viral replication in animal
models, as well as for the development of the full patho-
genic potential of these viruses. Strikingly, despite lim-
ited sequence similarity between HIV-1 and SIV Nef
proteins, SIV strains containing the HIV-1 nef gene in
place of SIV nef replicate efficiently in rhesus monkeys
and induce pathogenicity. Hence, the two proteins are
considered to be functional homologues. The mecha-
nisms and precise functions by which Nef modulates
viral replication and pathogenicity, however, still remain
poorly defined.
At least three functions have been described in vitro,
shared by both HIV-1 and SIV Nef, and may contribute to
their role in vivo. First, Nef increases viral replication and
infectivity (Miller et al., 1994; Sinclair et al., 1997; Spina et
al., 1994). Second, Nef triggers and/or enhances the
down-regulation of several cell surface receptors, includ-
ing CD4, class I major histocompatibility complex (MHC)
molecules, and the CD28 coreceptor (for review see
Oldridge and Marsh, 1998; Piguet et al., 1999; Skowron-
ski et al., 1999). SIV but not HIV-1 Nef also down-regu-
1 Sequence data from this article have been deposited with the
GenBank Data Library under Accession Nos. AJ320181 (Macaca fas-
cicularis mRNA for hck protein), AJ320182 (Hylobates sp. mRNA for Ick
protein), and AJ320183 (Hylobates sp. mRNA for fyn protein.© 2002 Elsevier Science (USA)
All rights reserved.
320lates the T cell receptor (TcR)–CD3 complex from the cell
surface (Bell et al., 1998; Howe et al., 1998). Third, in T
cells, Nef connects to the TcR-CD3 signaling machinery
and induces a state of partial T cell activation that man-
ifests itself by: (i) elevated Ca2-dependent signaling and
both nuclear factor of activated T cell (NFAT)- and NF-
B-mediated transcription (Luo and Peterlin, 1997; Man-
ninen et al., 2000; Wang et al., 2000); (ii) up-regulation of
FasL expression (Hodge et al., 1998; Zauli et al., 1999);
and (iii) the synergistic up-regulation of IL-2 expression
induced by suboptimal signals (Schrager and Marsh,
1999; Wang et al., 2000). In addition to these positive
effects of Nef on T cell signaling, inhibition of proximal
and distal TcR–CD3-triggered signaling has been re-
ported, which may reflect Nef titration of cellular factors
required for optimal TcR–CD3-mediated signaling (Col-
lette et al., 1996a,b; Greenway et al., 1995; Iafrate et al.,
1997; Luria et al., 1991). In myelomonocytic cells, Nef was
also found to alter Ca2 signaling (Foti et al., 1999) and to
induce CC-chemokine secretion (Swingler et al., 1999),
indicating that perturbation of intracellular signaling by
Nef is not restricted to T cells.
Together, these functions are likely to provide the virus
with an intracellular milieu that supports optimal viral
replication and infectivity. Similarly, immune perturbation
of cell functions, including class I MHC molecules and
cytokine/chemokine regulation together with FasL induc-
tion, is likely to allow the infected cells to evade immune
cell recognition and to recruit novel target cells at the
site of infection. Hence, the identification of the mecha-
nisms of action and the cellular factors involved in Nefrespective natural host-derived cellular targets. We clone
biochemically its interaction with SIV Nef. © 2002 Elsevier Sc
2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (33) 491 26 03 64. E-mail: collette@marseille.inserm.fr.
doi:10.1006/viro.2002.1381, available online at http://www.idealibrary.com
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functions has become a critical task.
Numerous Nef cellular partners have been identified,d sim
ience (U
on
including serine/threonine and tyrosine protein kinases
involved in signal transduction (Herna Remkema and
Saksela, 2000). Src family tyrosine kinases are of partic-
ular interest because of their multiple roles in the hema-
topoietic system, such as the regulation of T cell activa-
tion, cytokine/chemokine secretion, FasL induction, and
regulation of cell surface receptors (for a review, see
Korade-Mirnics and Corey, 2000). Interaction of Nef with
Src kinases is direct and involves a highly conserved
PxxP motif in addition to more distant residues forming a
large Src-binding surface. The Src-binding surface ap-
pears to be of critical importance in the biological func-
tion of HIV-1 Nef (Renkema and Saksela, 2000). However,
this molecular surface is differently implicated in SIV Nef
functions, raising the question of its role in the replicative
cycle of primate lentiviruses. Remarkably, whereas dis-
ruption of the PxxP motif precludes or largely reduces
tyrosine kinases binding by HIV-1 Nef (Saksela et al.,
1995), introduction of a similar mutation in SIV Nef does
not affect tyrosine kinase interaction (Greenway et al.,
1999; Lang et al., 1997). Instead, the N-terminus of SIV
Nef is responsible for Src kinase binding (Greenway et
al., 1999). Such genetically separable functions may re-
flect independent selection, during evolution, of different
mechanisms of interaction of HIV-1 and SIV Nef proteins
with cellular proteins. However, such a comparative
analysis has never been undertaken using SIV natural
host-derived cellular targets.
RESULTS
In human tissues, hck is specifically expressed in
myelomonocytic cells; hence, we used monocytes/mac-
rophages contained in broncho-alveolar washes ob-
tained from an experimentally infected cynomolgus ma-
caque (a kind gift from D. Dormont, CEA, Paris, France)
as the source for hck mRNA. The sequence alignment
between the available human and mouse Src sequences
showed a high sequence conservation and allowed us to
design primers using the first 22 bp beginning at the start
codon (5 primer) and the last 22 nucleotides including
the stop codon (3 primer) from Hck. RT-PCR was con-
ducted and the amplified products were subcloned fol-
lowed by sequencing (Fig. 1A; see footnote 1 for Gen-
Bank accession numbers). The cloned simian Hck se-
quences show 97.8% amino acid residue identity with
their human counterparts and 94% with mouse se-
quences (not shown). A phylogenetic tree was con-
structed and shows that the cloned Hck sequence dis-
plays the expected position for an orthologue and is
therefore considered to be the simian orthologue of the
human and mouse sequences present in the databases
(Fig. 1B). Alignment of the cloned Hck sequence with its
human counterpart shows the common domain organi-
zation with each segment designated as a Src homology
(SH) domain. These include the N-terminal SH4 domain,
which is a myristylation and membrane localization sig-
nal, followed by a “unique region” of 50–70 residues with
no significant similarity across the family members. The
SH3, SH2, and the catalytic SH1 domains follow, with two
additional functional regions located between the SH2
and the SH1 domains (SH2–SH1 linker) and at the C-
terminal “tail,” which contains a critical tyrosine residue.
Importantly, the residues that are critically involved in the
structure and function of these domains are strictly con-
served, including myristylation (Gly2) and acylation (Cys
3 and 5 and Lys 7 and 9) sites in the SH4 domain, the
active site residues (inverted triangles in Fig. 1A), the
major phosphorylation sites (black dots in Fig. 1A), as
well as the residues targeted by the specific Src kinase
inhibitor PP1 (labeled by a P in Fig. 1A) (Schindler et al.,
1999). Using the available human Hck crystal we also
modeled the simian Hck putative structure (98.2% homol-
ogy with the corresponding human Hck structure). Figure
1C shows a highly ordered, compactly organized overall
structure, identical to that of the solved structure of
human Hck (Schindler et al., 1999; Sicheri et al., 1997).
Next, the simian hck coding sequences were sub-
cloned in a eukaryotic expression vector, transfected as
previously described (Collette et al., 2000) in the simian
COS-7 cell line (which expresses a very low background
src kinase activity), and checked for expression and
catalytic function. Because of the high level of conserva-
tion between the human and simian amino acid se-
quences, transfected cell lysates were analyzed by West-
ern blotting and enhanced chemiluminescence as de-
scribed (Greenway et al., 1999), using a monoclonal
antibody directed against human Hck (Fig. 1D). The sim-
ian Hck was expressed at similar levels, compared to the
human Hck, and displayed high autophosphorylation ac-
tivity, as evidenced by stripping and reprobing the mem-
branes using anti-phosphotyrosine antibodies (Fig. 1D).
Autophosphorylation and phosphorylation of exogenous
substrates in an in vitro kinase assay were both inhibited
by the specific PPI Src inhibitor (not shown). Together,
these results show that the cloned simian Hck tyrosine
kinase is nearly identical to its human orthologue.
The interaction of HA-tagged SIV Nefmac239 (Collette
et al., 2000) with its specific host cellular Hck kinase was
investigated by cotransfection of the COS-7 cell line.
Transfected cells were lysed, immunoprecipitated with
the specific Hck antibody, and analyzed by anti-HA West-
ern blotting. As shown in Fig. 2, HA-tagged SIV Nef-
mac239 coimmunoprecipitated with both human- and
simian-derived Hck. As a control for the cross-reactivity
of the Hck antibody, HA-tagged SIV Nefmac239 was not
detected in the immunoprecipitates obtained from cells
transfected in the absence of simian or human Hck.
Under these experimental conditions, we found no evi-
dence for a preferential interaction of SIV Nef with simian
compared to human Hck.
Nef from the aggressive strain SIV pbj14 and, to a
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lesser extent, from SIVmac239 was found to be tyrosine
phosphorylated upon coexpression with human Src ki-
nases (Du et al., 1995; Lang et al., 1997). Thus, HA-tagged
SIV Nefmac239 was coexpressed with simian and hu-
man Hck in COS-7 cells and immunoprecipitated by the
HA-specific monoclonal antibody followed by anti-phos-
photyrosine Western blotting. Figure 2B shows that SIV
Nefmac239 was tyrosine phosphorylated upon coex-
pression with either human or simian Hck, but not de-
tectably when expressed in the absence of the Src ki-
nases (lane 3). Both the human and simian coexpressed
tyrosine phosphorylated Hck proteins coimmunoprecipi-
tated with the HA-tagged SIV Nef.
We and others have previously reported that HIV-1 and
SIV Nef can modulate human Src kinase activity (Briggs
et al., 1997; Collette et al., 1996b; Greenway et al., 1996,
1999; Moarefi et al., 1997). We thus included in a previ-
ously described in vitro kinase assay (Greenway et al.,
1996, 1999) human and simian Hck immunoprecipitated
from transfected COS-7 cells together with recombinant
GST–Nef fusion proteins and substrate peptides. As
shown in Fig. 3 and Table 1, both GST–HIV-1 and –SIV
Nef recombinant proteins increased either human or
simian Hck catalytic activity by six- to eightfold, com-
pared to GST alone. Whereas the regulation of either
simian or human Hck by HIV-1 Nef required an intact
FIG. 2. Interaction of SIV Nef with simian Hck tyrosine kinase. (A)
COS-7 cells were cotransfected by constructs encoding the HA-tagged
SIVmac239 Nef and human or simian Hck or the empty expression
vector (). 48 h after transfection, cells were lysed and proteins were
immunoprecipitated by Hck antibodies followed by Western blot anal-
ysis with the 3F10 anti-HA monoclonal antibody. Membranes were
stripped and reprobed with the Hck antibodies to verify the immuno-
precipitation of the protein tyrosine kinase. Whole-cell lysates (WCL)
were also analyzed by anti-HA immunoblotting to verify that similar
levels of SIV Nef were reached in the different transfected cells. (B)
Human (H), simian (S) Hck, or empty () expression constructs were
cotransfected with constructs encoding the HA-tagged SIVmac239 Nef
(lanes 1 and 2) or empty vector (lane 3 and 4). 48 h after transfection,
cells were lysed and proteins were immunoprecipitated by the 3F10
anti-HA monoclonal antibody followed by anti-phosphotyrosine immu-
noblotting. Membranes were stripped and reprobed with the 3F10
anti-HA monoclonal antibody to verify the immunoprecipitation of HA-
tagged SIVmac239 Nef.
FIG. 1. Structural and functional characterization of simian Hck Src family tyrosine kinase. (A) Alignment of the human and simian Hck sequences
using Clustal W (Blosum 30 matrix). Simian sequences were PCR-amplified as described in the text, while the human sequences were retrieved from
human databases. The beginning and the end of the SH1, SH2, SH3, and SH4 domains are indicated by arrows. Active-site residues are indicated
by inverted triangles. Filled triangles indicate salt bridges forming residues implicated in the positioning of ATP. Residues implicated in the folding
and intramolecular interactions of the SH2–SH1 linker with the SH3 domain and the N-terminal kinase lobe are indicated by squares. Major regulatory
phosphorylation sites are indicated by dots. Selective residues for the specific Src kinase inhibitor PP1 binding are indicated by a P. (B) Phylogenetic
tree showing the relationship between human, simian, and murine Hck, as well as the human Lck tyrosine kinases based on the alignment of their
SH1 domain. (C) Secondary structure of simian Hck using SWISS-MODEL (Version 36.0002) and the available human Hck as a template structure.
The model was prepared using SwissPdbViewer (version 36.b2). (D) Expression and phosphorylation of simian Hck in COS-7 cells. Human (H), simian
(S) Hck, or empty () expression constructs were transfected in COS-7 cells followed by Western blotting, using specific Hck (top) and anti-
phosphotyrosine antibodies (bottom).
FIG. 3. Differential effect of HIV and SIV Nef on Hck catalytic activity
in vitro. Human Hck and simian Hck were immunoprecipitated from
transfected COS-7 cells followed by preincubation with 100 nM GST,
GST–HIV-Nef, or GST–SIV-Nef, added to the peptide p34cdc2 [Lys 19
(6-20)NH2] or the control peptide p34
cdc2 [Lys 19 Phe 15 (6-20)NH2] and
subjected to kinase assay. Incorporation of [32P]ATP was measured by
scintillation counting. Results are expressed as a percentage of un-
treated kinase activity after subtraction of the control peptide from the
test samples. Results are representative of three independent experi-
ments with less than 10% variation.
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PxxP motif (Table 1) (Greenway et al., 1999), SIV Nef
increased each of the human and simian kinase catalytic
activities independent of its otherwise conserved PxxP
motif (Table 1). Instead, the N-terminal amino acids 1–57
from SIV Nefmac239 fused to GST were sufficient to
account for either human or simian Hck catalytic up-
regulation (Table 1) (Greenway et al., 1999).
DISCUSSION
Despite overlapping functions and targeting of similar
cellular proteins, HIV-1 Nef and SIV Nef are thought to
have evolved different molecular strategies for protein–
protein interactions (Bresnahan et al., 1998; Craig et al.,
1998; Greenberg et al., 1998). However, the interaction of
SIV and HIV-1 Nef with their respective host-derived
cellular targets has never been compared. Hence, the
genetically separable functions may reflect differential
adaptation to different molecular surfaces of the host
cellular factors. Here we cloned, sequenced, and char-
acterized simian Hck from cynomolgus macaques and
established the near identical structural and functional
features shared with its human orthologue. We show that
SIV Nefmac239 can interact with and increase the cata-
lytic activity of simian as well as human Hck. Binding of
Nef to Hck (in monocytes) and Lck (in T cells) involves
the SH2 and/or SH3 domains and the PxxP and/or an as
yet unidentified motif in the N-terminus of Nef (Collette et
al., 1996b; Dutartre et al., 1998; Greenway et al., 1999;
Saksela et al., 1995). Remarkably, disruption of the PxxP
motif precludes or largely reduces human, but also sim-
ian, Src family kinase binding by HIV-1 Nef (Saksela et
al., 1995). Conversely, introduction of a similar mutation
in SIV Nef is without consequence to either human and
simian Src kinase regulation (Greenway et al., 1999;
Lang et al., 1997; the present report). Instead, the N-
terminus of SIV Nef accounts for human (Greenway et al.,
1999), and also simian, Src kinase regulation (the
present article), possibly through tyrosine phosphoryla-
tion and subsequent SH2 binding (Du et al., 1995; Luo
and Peterlin, 1997).
In addition to this differential implication of the PxxP
motif in Src kinase SH3 domain binding, we have re-
ported a selective human Src kinase SH3 domain inter-
action with HIV-1 and SIV Nef (Collette et al., 2000). While
HIV-1 Nef presents high avidity for human Hck SH3
(KD  20 nM), it has 100-fold lower affinity toward human
Fyn SH3 (Lee et al., 1995). Biochemical and structural
studies have revealed that, in addition to the critical PxxP
motif, this selectivity is mostly the result of an extended
binding surface implicating distant residues forming a
hydrophobic pocket. This pocket accommodates the
side chain of an isoleucine from the human Hck SH3
domain RT-loop (Arold et al., 1997, 1998; Lee et al., 1995,
1996). The single substitution by isoleucine for the cor-
responding charged arginine residue from the Fyn SH3
RT-loop allows HIV-1 Nef binding (Lee et al., 1995). Con-
versely, based on the available HIV-1 crystal structure,
we modeled SIV Nef and identified the insertion of two
charged residues in the region corresponding to the
HIV-1 Nef hydrophobic pocket predicted to account for
the lack of Hck SH3 binding by SIV Nef (Collette et al.,
2000). Indeed, substitution of these residues by the cor-
responding HIV-1 Nef residues allowed strong binding of
SIV Nef to Hck SH3 (Collette et al., 2000). The simian Hck
SH3 domain is 100% identical to the human Hck SH3
(Fig. 1A). Hence, the absence of binding of SIV Nef-
mac239 to Hck SH3, compared to the high avidity of
HIV-1 Nef for the same domain (Greenway et al., 1999),
strictly reflects differences in the SIV Nef molecular sur-
face compared to HIV-1 Nef (see model in Fig. 4). Clearly,
different molecular surfaces are implicated in Src bind-
ing and regulation by HIV-1 and SIV Nef proteins, while
human Hck and simian Hck show identical or very sim-
ilar structural and functional features. We further cloned
the simian Lck and Fyn Src family tyrosine kinases (data
not shown; sequences were deposited with GenBank)
and obtained similar results. The present report hence
strongly supports the concept that HIV-1 and SIV under-
went convergent evolution and that different molecular
strategies were selected with a similar outcome, at least
regarding the Nef–Src kinase interface. Strikingly, the
integrity of the PxxP motif is required in various functions
of HIV-1 Nef described in vitro, including the down-
regulation of class I MHC molecules from the cell sur-
TABLE 1
Different Molecular Surfaces Are Required for Catalytic Regulation of Simian Hck by HIV and SIV Nef
HIV-1
Nef
HIV-1 Nef
AxxA SIV Nef
SIV Nef
1–57
SIV Nef
AxxA GST
Kinase alone
 peptide
Kinase alone
 control peptide
Simian Hck 2,689,300 443,100 3,277,500 3,143,020 2,969,000 397,300 420,200 31,000
Human Hck 4,127,700 492,900 3,645,800 3,837,600 3,337,100 487,600 513,400 71,300
Note. The human Hck and simian Hck were subjected to kinase assay as described in the legend to Fig. 3, using 100 nM GST, GST–HIV-1-Nef,
GST–HIV-1-NefAxxA (Nef mutant with substitution of the PxxP motif to AxxA), GST–SIV-Nef, GST–SIV-Nef-1-57 (amino acids 1 to 57 from SIVmac239
Nef), or GST–SIV-Nef-AxxA. Incorporation of [32P]ATP was measured by scintillation counting. Results are expressed as cpm and are representative
of three independent experiments with less than 10% variation.
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face (Greenberg et al., 1998; Mangasarian et al., 1999;
Swigut et al., 2000), regulation of viral replication (Sak-
sela et al., 1995; Wiskerchen and Cheng, 1996), modula-
tion of intracellular signaling (Herna Remkema and Sak-
sela, 2000), induction of FasL expression (Zauli et al.,
1999), and binding to Src family and PAK kinases (for
review, see Herna Remkema and Saksela, 2000). Since
the PxxP motif is very well conserved in up to 1000
different Nef sequences described in the databases,
including HIV-2 and SIV Nef (Collette et al., 2000), it is
considered to be a critical functional motif. However,
mutation of this PxxP motif does not alter the replicative
or pathogenic potential of SIV upon experimental infec-
tion of macaques (Carl et al., 2000; Khan et al., 1998;
Lang et al., 1997). Since disruption of this motif precludes
the interaction of SIV Nef with PAK kinases, but pre-
serves Src binding and catalytic regulation by SIV Nef,
these results highlight the importance of understanding
further the role of the Src kinases in the in vivo replica-
tion and pathogenicity of primate lentiviruses. The mate-
rial described herein will provide useful reagents to this
end. If the Nef–Src kinase interface is considered for
drug design, one consequence of the present report is
that the testing of such HIV-1 inhibitory compounds in
simian animal models will require the use of SHIV–Nef
virus in order to probe for the relevant functional sur-
faces.
MATERIAL AND METHODS
RT-PCR
RT-PCR was conducted as previously described (Col-
lette et al., 1996a), using M-MLV reverse transcriptase
(Gibco BRL) and Taq Advantage proofreading polymer-
ase (Clontech). The amplified products were subcloned
in pGEM-T Easy (Promega), followed by sequencing.
Phylogenetic analysis and structure modeling
Multiple alignments were constructed using Clustal X
with the default parameters on selected gene families.
The phylogenetic tree was produced from the Clustal W
multiple alignment output, using Mega version 2.0, which
is an updated version of MEGA. The simian Hck putative
structure was modeled using the available human Hck
crystal structure and SWISS-MODEL Version 36.0002
(Guex et al., 1999).
Western blotting and immunoprecipitation
The simian hck coding sequences were subcloned as
EcoRI fragments in the DNA4 eukaryotic expression
vector, transfected as previously described (Collette et
al., 2000) in the simian COS-7 cell line, and analyzed by
Western blotting and enhanced chemiluminescence as
described (Greenway et al., 1999), using specific mono-
clonal antibodies against human Hck (Santa Cruz, N30)
or the anti-phosphotyrosine monoclonal antibody 4G10
(Upstate Biotechnology). HA-tagged Nef protein was im-
munoprecipitated using anti-HA monoclonal antibody
(clone 3F10, Roche), as previously described (Collette et
al., 2000).
Kinase assay
Simian and human Src kinases derived from trans-
fected COS-7 cells were immunoprecipitated and in-
cluded in a kinase assay together with GST recombinant
proteins and the peptide p34cdc2 [Lys 19 (6-20)NH2] or the
control peptide p34cdc2 [Lys 19 Phe 15 (6-20)NH2], as
previously described (Greenway et al., 1999).
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